Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi (VICAL)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Basilea Pharmaceutica International Ltd
Information provided by (Responsible Party):
Astellas Pharma Inc
ClinicalTrials.gov Identifier:
NCT00634049
First received: March 5, 2008
Last updated: June 2, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2014
  Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)